|

Standard of Care Endocrine Therapy Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • RayzeBio, Inc.1

Indications

  • Hormone-Sensitive Breast Cancer1
  • Hormone-sensitive Metastatic Breast Cancer1
  • Bone Metastases in Subjects With Advanced Breast Cancer1
  • Metastatic Breast Cancer With Bone Involvement1
  • ER-Positive HER2-Negative Breast Cancer1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.